Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | The potential role of metformin in the treatment of Parkinson’s disease

K. Ray Chaudhuri • 29 May 2020
EAN 2020
Movement Disorders Parkinson's Disease Metformin

K Ray-Chaudhuri, FRCP (Lond), FRCP (Edin), MD, DSc, King’s College London, London, UK, outlines the possible effects of metformin therapy on motor and non-motor features of diabetic patients with Parkinson’s disease. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from K. Ray Chaudhuri

1:49
Early Parkinson's detection: identifying prodromal signs and ethical considerations
K. Ray Chaudhuri • 3 Jul 2023
1:20
Foslevodopa/foscarbidopa improves nocturia symptoms in patients with Parkinson’s disease
K. Ray Chaudhuri • 29 Aug 2023
3:31
Challenges faced in the clinical assessment of non-motor features in Parkinson’s disease
K. Ray Chaudhuri • 29 Aug 2023
4:14
Advances in the assessment and treatment of non-motor symptoms in Parkinson’s disease
K. Ray Chaudhuri • 29 Aug 2023

Related Videos

1:19
The potential of cell and gene therapy in treating Parkinson’s disease
Fabrizio Stocchi • 7 Mar 2024
4:11
Updates on current Parkinson’s disease clinical trials
Fabrizio Stocchi • 7 Mar 2024
3:42
NfL shows strong prognostic value in pre-manifest Huntington's disease
Natalia E. Owen • 8 Mar 2024
5:26
Pridopidine shows benefit for patients with early HD not on antidopaminergic therapies
Michael Hayden • 16 Apr 2024
The content of VJNeurology is intended for healthcare professionals